New quantitative analysis, using high-resolution images, of oxygen-induced retinal neovascularization in mice

Experimental Eye Research

Volumn 84, Issue 3, 2007, Pages 529-536

  Chikaraishi, Yuichi ^a   Shimazawa, Masamitsu ^a   Hara, Hideaki ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

mice; neovascularization; oxygen induced retinopathy; quantificational evaluation; retinal vasculature

Indexed keywords

DEXTRAN; FLUORESCEIN; OXYGEN;

AMBIENT AIR; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPUTER PROGRAM; CONTROLLED STUDY; IMAGING SYSTEM; MOUSE; NONHUMAN; PERFUSION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA BLOOD VESSEL; RETINA NEOVASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; FLUORESCEIN ANGIOGRAPHY; HYPEROXIA; IMAGE PROCESSING, COMPUTER-ASSISTED; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; OXYGEN INHALATION THERAPY; RETINAL NEOVASCULARIZATION; RETINAL VESSELS;

EID: 33846841064     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exer.2006.11.007     Document Type: Article

References (26)

1. Aiello L.P., Northrup J.M., Keyt B.A., Takagi H., and Iwamoto M.A. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch. Ophthalmol. 113 (1995) 1538-1544
2. Aiello L.P., Pierce E.A., Foley E.D., Takagi H., Chen H., Riddle L., Ferrara N., King G.L., and Smith L.E. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 10457-10461
3. Aiello L.P., Gardner T.W., King G.L., Blankenship G., Cavallerano J.D., and Klein R. Diabetic retinopathy. Diabetes Care 21 (1998) 143-156
4. Al-Shabrawey M., El-Remessy A., Gu X., Brooks S.S., Hamed M.S., Huang P., and Caldwell R.B. Normal vascular development in mice deficient in endothelial NO synthase: possible role of neuronal NO synthase. Mol. Vis. 9 (2003) 549-558
5. Al-Shabrawey M., Bartoli M., El-Remessy A.B., Platt D.H., Matragoon S., Behzadian M.A., Caldwell R.W., and Caldwell R.B. Inhibition of NAD(P)H oxidase activity blocks vascular endothelial growth factor overexpression and neovascularization during ischemic retinopathy. Am. J. Pathol. 167 (2005) 599-607
6. Bainbridge J.W., Mistry A., De Alwis M., Paleolog E., Baker A., Thrasher A.J., and Ali R.R. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene. Ther. 9 (2002) 320-326
7. Banin E., Dorrell M.I., Aguilar E., Ritter M.R., Aderman C.M., Smith A.C., Friedlander J., and Friedlander M. T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Investig. Ophthalmol. Vis. Sci. 47 (2006) 2125-2134
8. Campochiaro P.A., and Hackett S.F. Ocular neovascularization: a valuable model system. Oncogene 22 (2003) 6537-6548
9. Das A., McLamore A., Song W., and McGuire P.G. Retinal neovascularization is suppressed with a matrix metalloproteinase inhibitor. Arch. Ophthalmol. 117 (1999) 498-503
10. Danis R.P., and Yang Y. Microvascular retinopathy in the Zucker diabetic fatty rat. Investig. Ophthalmol. Vis. Sci. 34 (1993) 2367-2371
11. Eyetech Study Group. Preclinical and phase 1A clinical evaluation of an anti-VEGF pegylated aptamer (EYE001) for the treatment of exudative age-related macular degeneration. Retina 22 (2002) 143-152
12. ® (AG3340), a matrix metalloprotease inhibitor, in treatment of retinal neovascularization. Curr. Eye Res. 24 (2002) 33-38
13. Gardiner T.A., Gibson D.S., de Gooyer T.E., de la Cruz V.F., McDonald D.M., and Stitt A.W. Inhibition of tumor necrosis factor-alpha improves physiological angiogenesis and reduces pathological neovascularization in ischemic retinopathy. Am. J. Pathol. 166 (2005) 637-644
14. Higgins R.D., Yu K., Sanders R.J., Nandgaonkar B.N., Rotschild T., and Rifkin D.B. Diltiazem reduces retinal neovascularization in a mouse model of oxygen induced retinopathy. Curr. Eye Res. 18 (1999) 20-27
15. Madan A., and Penn J.S. Animal models of oxygen-induced retinopathy. Front. Biosci. 8 (2003) 1030-1043
16. McGuire P.G., Jones T.R., Talarico N., Warren E., and Das A. The urokinase/urokinase receptor system in retinal neovascularization: inhibition by A6 suggests a new therapeutic target. Investig. Ophthalmol. Vis. Sci. 44 (2003) 2736-2742
17. Nagai N., Noda K., Urano T., Kubota Y., Shinoda H., Koto T., Shinoda K., Inoue M., Shiomi T., Ikeda E., Tsubota K., Suda T., Oike Y., and Ishida S. Selective suppression of pathologic, but not physiologic, retinal neovascularization by blocking the angiotensin II type 1 receptor. Investig. Ophthalmol. Vis. Sci. 46 (2005) 1078-1084
18. Nandgaonkar B.N., Rotschild T., Yu K., and Higgins R.D. Indomethacin improves oxygen-induced retinopathy in the mouse. Pediatr. Res. 46 (1999) 184-188
19. Penn J.S., and Gay C.A. Computerized digital image analysis of retinal vessel density: application to normoxic and hyperoxic rearing of the newborn rat. Exp. Eye Res. 54 (1992) 329-336
20. Robison W.G., Laver N.M., Jacot J.L., and Glover J.P. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model. Investig. Ophthalmol. Vis. Sci. 36 (1995) 2368-2380
21. Reynaud X., and Dorey C.K. Extraretinal neovascularization induced by hypoxic episodes in the neonatal rat. Investig. Ophthalmol. Vis. Sci. 35 (1994) 3169-3177
22. Rotschild T., Nandgaonkar B.N., Yu K., and Higgins R.D. Dexamethasone reduces oxygen induced retinopathy in a mouse model. Pediatr. Res. 46 (1999) 94-100
23. Sharma J., Barr S.M., Geng Y., Yun Y., and Higgins R.D. Ibuprofen improves oxygen-induced retinopathy in a mouse model. Curr. Eye Res. 27 (2003) 309-314
24. Smith L.E., Wesolowski E., McLellan A., Kostyk S.K., D'Amato R., Sullivan R., and D'Amore P.A. Oxygen-induced retinopathy in the mouse. Investig. Ophthalmol. Vis. Sci. 35 (1994) 101-111
25. Spandau U.H., Sauder G., Schubert U., Hammes H.P., and Jonas J.B. Effect of triamcinolone acetonide on proliferation of retinal endothelial cells in vitro and in vivo. Br. J. Ophthalmol. 89 (2005) 745-747
26. Wilkinson-Berka J.L., Alousis N.S., Kelly D.J., and Gilbert R.E. COX-2 inhibition and retinal angiogenesis in a mouse model of retinopathy of prematurity. Investig. Ophthalmol. Vis. Sci. 44 (2003) 974-979